Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour
NCT ID: NCT04846621
Last Updated: 2021-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
230 participants
INTERVENTIONAL
2020-06-01
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
aim of the study: To assess the efficacy of Nicorandil compared with Nifedipine as a tocolytic agent in delaying labour for 48 hours following their administration
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Nifedipine in the Management of Preterm Labor
NCT04644354
Management of Acute Preterm Labor: Nifedipen Alone or Combined With Cildenafil Citrate
NCT02337881
Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
NCT03129945
Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate
NCT06904534
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs
NCT05345132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The diagnosis of preterm labor based upon clinical criteria of regular painful uterine contractions occurs between 20 weeks and before 37 weeks gestation accompanied by cervical change (dilation and/or effacement). Vaginal bleeding and/or ruptured membranes in this setting increase diagnostic certainty , using the following specific criteria:
Uterine contractions (≥4 every 20 minutes or ≥8 in 60 minutes) Plus one of the following:-
* Cervical dilation equal or more than 3 cm
* Cervical length less than 20 mm on transvaginal ultrasound
* Cervical length between 20 to less than 30 mm on transvaginal ultrasound and positive fetal fibronectin test . (This criterion will not be relied upon in this study because it is costly and widely not available in most laboratories)
Since uterine contractions are the most frequently recognized sign of preterm labor, inhibition of uterine contractions with tocolytic agents to prolong pregnancy and reduce neonatal complications has been and continues to be the focus of treatment of preterm labor
• Nifedipine, a calcium channel blocker, could be used as a first line tocolytic agent
Owing to this side effects of Nifedipine, another novel drug (Nicorandil) is studied and according to literature Nicorandil is as effective as Nifedipine for tocolysis in preterm labour
is an anti-angina medication that has the dual properties of a nitrate and ATP-sensitive K+ channel activator. Nicorandil has proved to be safe as anti angina treatement in pergnency
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group Nicorandil
women will receive oral Nicorandil 20 mg initially followed by 10 mg at 8 hourly intervals for 48 hours
Potassium Channel Opener
Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor
group Nifedipine
Women will receive oral Nifedipine loading dose 20 mg orally followed by 10 mg every 8 hours for 48 hours
Calcium channel blocker
Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Potassium Channel Opener
Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor
Calcium channel blocker
Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pregnant female with single viable fetus who presented to the outpatient clinic or Emergency room with the criteria of diagnosis of preterm labor between 28 and before completing 34 weeks pregnancy
Exclusion Criteria
* Cervix dilatation greater than 4 cm.
* Polyhydramnios \[amniotic fluid index (AFI) greater than 24 cm or deep vertical pocket more than 8 cm.\]
* Oligohydramnios (AFI less than 5 cm).
* Suspected intrauterine infection if Maternal fever is present as a constant feature plus one or more of the following:-
* Maternal leucocytosis (more than 15,000)
* purulent vaginal discharge
* Fetal tachycardia more than 180 bpm.
* Growth restriction.
* Major antepartum hemorrhage
* Major maternal medical disorders such as diabetes, hypertension, systemic lupus,liver and kidney dysfunction .
* Multiple gestation pregnancy.
* Signs of fetal non reassuring CTG
* Signs of fetal abnormal CTG
* Lethal fetal anomaly incompatible with life.
* Premature Rupture of membrane.
--Contraindication for the use of Nifedipine and/or Nicorandil such as drug allergy, cardiac disease, liver disease and kidney disease
* previous caesarean section
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manella fayez
Miami, Alexandria Egypt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
manella beshara, master
Role: PRINCIPAL_INVESTIGATOR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manella Fayez Zaki Beshara
Egypt, Alexandria Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, Price MJ, Morris K, Gallos ID. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD014978. doi: 10.1002/14651858.CD014978.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
preterm labor tocolysis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.